Filing Details
- Accession Number:
- 0001209191-22-008267
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2022-02-09 21:00:29
- Reporting Period:
- 2022-01-31
- Accepted Time:
- 2022-02-09 21:00:29
- Original Submission Date:
- 2022-02-02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
899460 | Mannkind Corp | MNKD | Pharmaceutical Preparations (2834) | 133607736 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1674282 | Michael Castagna | 30930 Russell Ranch Road Suite 300 Westlake Village CA 91362 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Acquisiton | 2022-01-31 | 1,804 | $3.17 | 1,505,098 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The reporting person purchased shares through the Company's Employee Stock Purchase Plan on January 31, 2022. The amended number of shares purchased were limited by Section 423(b)(8) of the Code.